|
|
|
|
|
21.11.25 - 16:57
|
Don′t Fight The Fed... But Is China Worth A Shot? (ZeroHedge)
|
|
|
Don't Fight The Fed... But Is China Worth A Shot?
By Daniel Moss, Bloomberg Markets Live reporter
The idea of taking out insurance against worst-case scenarios, mostly by cutting interest rates, became a popular choice among the world's big central banks over the past quarter century. Beijing has shunned this doctrine lately. It may come with a price.
The People's Bank of China recently downplayed concerns that the world's second-largest economy is in trouble. The PBOC's latest quarterly statement emphasized long-term prospects and discouraged investors from focusing on what it sees as merely short-term hurdles. Translation: Rein in those bets on rate cuts. Goldman Sachs was among those that got the message, pushing back its forecast for the next reduction to the first quarter of 2026. Other large institutions, including Citigroup Inc., had already thrown in the towel.
It's natural that firms adjust projections to reflect what central banks are saying, as opposed to relying entir...
|
|
|
|
|
|
|
|
|
21.11.25 - 14:06
|
Innovent, first Chinese firm to market weight-loss drug, joins Hang Seng Index (SCMP)
|
|
|
Innovent Biologics will join the Hang Seng Index next month in the latest quarterly review as the compiler of the city's stock benchmark presses ahead with its plan to increase the number of constituents to 100.
The biotech firm, based in eastern Jiangsu province, has become the only new constituent of the blue-chip indicator, one month after it signed an US$11.4 billion outsourcing deal with Japan's Takeda Pharmaceuticals to co-develop and commercialise three specific investigational cancer......
|
|
|
|
|
21.11.25 - 13:36
|
Beyond US-China decoupling, self-reliance is now a global movement (SCMP)
|
|
|
My recent visit to Mianyang, the second-largest city in Sichuan province, revealed a place little known despite being just a 90-minute drive from Chengdu. Its unique distinction lies in its high concentration of scientists – a legacy of its role as a central hub during the “Third Front Construction” from 1964 to 1978. This was a critical period when China relocated strategic industries inland to build a self-reliant economy against a backdrop of external threats.
This era formed the second of......
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
21.11.25 - 09:48
|
US$44 million sale of Hong Kong luxury home linked to mainland Chinese investor (SCMP)
|
|
|
A buyer bearing the same name as veteran investor Xu Liusheng is the latest owner of a luxury home in Hong Kong after acquiring a HK$342 million (US$43.9 million) unit in the affluent Southern district, with the transaction adding to a growing list of prime assets being snapped up following years of falling prices.
The buyer shares the name of the owner of Shenzhen Kaifu Investment, who is known for acquiring shares in public companies in mainland China. Shenzhen Kaifu was recently deregistered,......
|
|
|
|
|
|
Top- News zu China 14971.9745 -1.37% (China A50 Kurs)
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
